Excretion of catecholestrogens in women receiving estrogen-substitution therapy
β Scribed by L. M. Bershtein; E. V. Tsyrlina; O. S. Kolesnik; V. B. Gamayunova; I. G. Kovalenko; H. Aldercreutz
- Publisher
- Springer US
- Year
- 1999
- Tongue
- English
- Weight
- 248 KB
- Volume
- 128
- Category
- Article
- ISSN
- 0007-4888
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We analyzed cancer incidence and mortality in a cohort of 22,597 Swedish women who were prescribed replacement hormones. After 13 years of follow-up in national registries, 2,330 incident cancer cases and 848 cancer deaths were observed. Overall, our results were reassuring since incidence rate rati
Cancer risk following treatment with non-contraceptive estrogens was studied in a population-based cohort of 23,244 women. Complete follow-up for an average of 6.7 years revealed 1,087 incident cancers versus 962.5 expected (relative risk/RR/ = 1.13; 95% confidence interval 1.10-1.20). We confirmed